Atlas Trials

AryoTrust® (Trastuzumab) Safety Study

Clinical trial NCT06021379 · COMPLETED

Trial details

NCT number
NCT06021379
Sponsor
AryoGen Pharmed Co.
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2017-02-22
Primary completion
2022-08-28
Enrollment
597

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.